Q&A with Andrea Lechner-Becker, Chief Marketing Officer at LeadMD

MEDIA 7 | December 5, 2019

Q&A with Andrea Lechner-Becker
Andrea Lechner-Becker, Chief Marketing Officer at LeadMD is an experienced Marketing and Sales Executive with a demonstrated history of working in the marketing and advertising industry.

Skilled in Business Process, Marketo, Sales, Customer Relationship Management (CRM), and IT Service Management, Andrea is also a strong business development professional and a storyteller.

MEDIA 7: What inspired you to get into marketing?
ANDREA LECHNER: 
Frankly, not having better options. I originally attended the University of Wisconsin-La Crosse thinking I’d major in Archaeology. I wanted to be Indiana Jones! But, after visiting the archaeology building – i.e. the cold, dark basement of the science building – where a girl sat to piece together pieces of an old Native American vase, I knew archaeology was not going to be the right path for me. And so, without being good at science and a major in art or art history was unlikely to pay my bills, I decided to go into “business”. I originally registered as a management major, but took my first marketing class and thought it was more interesting and switched my sophomore year. That was pretty much it. I’d never been involved in business classes or DECA in high school – I didn’t really know what to do or what jobs in marketing were even possible. I dumb lucked myself into it really.

M7: As a storyteller, do you relate the brand to a story or story to the brand?
AL:
Both? Neither? I think there are stories in every brand, because there are people working on the brand and people engaging with the brand and people using what the brand creates. People, most often a single person, are at the heart of great stories.
You can start with the “point” of the story you’re trying to tell. Say you have a software that help accountants better create reports for board meetings. It’s likely you’ll want to tell a success story about an accountant getting promoted to CFO in part because your software helped better communicate their work product to the board. You could have the idea for that and go looking for that story in your customers. OR, you could hear that story, and say, “That’s amazing!” and share it with customers, partners and internal people. Stories are all around us – the most important thing is to keep your ears and eyes open for finding them.


"People, most often a single person, are at the heart of great stories. Stories are all around us – the most important thing is to keep your ears and eyes open for finding them."

M7: LeadMD has been named as Marketo’s platinum service partner. What are the core values that drive the company to be a leading marketing firm?
AL: 
About two years ago, we got to the size where we had to really dedicate some time to defining our core values. We got into a room with everyone in the company and talked about what it feels like to work at LeadMD. We decided on the following values, which all start with “We” because we’re a tribe and succeed together with our clients:

1. We over me. Our people will drop almost anything to help another member of the tribe and our clients. We are a performance organization and aim to ease the lives of those around us with valuable contribution.
2. We stand in your shoes. Empathy is so critical to our success internally and externally.
3. We are better than yesterday. Marketing is a discipline that must be creative and iterative. We don’t know everything, but we strategize, plan, do, review and optimize constantly. Together, we figure out what will garner the best results.
4. We believe in transparency. Transparency is function of trust. Trust is a function of reliability, competency, communication, authority and predictability. Our clients trust us with their vision and that's an honor we take seriously.
5. We have fun in everything we do. We like our tribe and our clients and we do cool sh*t together. It’s fun work.




"Until you execute learnings, test them and see if and how they work, none of it means anything. If in doubt, do something."

M7: What distinguishes LeadMD from the rest in creating predictable and sustainable revenue operations for enterprise brands?
AL:
 Our value to our clients is our ability to integrate strategic objectives with all the day-to-day actions of teams of people. We are great at rolling our sleeves up and truly creating scale around these elements that ultimately impact the organization as a whole. The results our clients see are things like, a technology company generating a $15 million lift in pipeline within 90 days and a medical device company generating $5 million in revenue in six months (which is like one month in healthcare timelines) in a typically down quarter. Ultimately, the work we collaborate with clients on, impacts the business in more revenue, faster.


M7: How does LeadMD’s methodology facilitate organizations in delivering exceptional outcomes that they desire?
AL: 
This may fall more under philosophy than methodology, but we work with leaders unwilling to maintain the status quo. We call them Catalysts. We work with people eager and willing to act to change a current poor performing outcome in their organization. We can help, but we are never going to be able to impact the types of outcomes we’re used to without internal champions and rainmakers. Our outcomes are in large part due to the fearless nature of our clients.


"Learning is about connective tissue and being able to connect new things to things that already make sense to you. Just do it. It’ll not only make you a better employee or entrepreneur, it’ll also make you a better person."

M7: You have co-founded an e-learning firm, Six Bricks. What was the learning experience from it and how has this accelerated your career journey?
AL: 
The learning experiences from that piece of my career are far too numerous to name in this QA. The best way I could sum them up is to say that doing something new will always hold value. As a long-time consultant, I’ve had lots of ideas about what professionals in sales and marketing could or should do. I’ve listened to a lot of podcasts, attended SaaStr’s annual conference and brought ideas back. But, until you execute on them, test them and see if and how they work, none of it means anything. If in doubt, do something.


M7: Going with the story of your book ‘Sixty Days Left’, how does exploring new marketing trends and making informed decisions create a fortune for any enterprise?
AL:
��I’m a big advocate for everyone, even executives, to explore trends and the news of their discipline at a fairly deep level. Just knowing artificial intelligence as a thing is “good” but not great. Lean in. Read opinions from people who have worked in artificial intelligence for years, who study it in a university setting, who can really break it down. The first AI article I read was really technical and I barely understood it, but I kept doing it and kept learning. Learning is about connective tissue and being able to connect new things to things that already make sense to you. Just do it. It’ll not only make you a better employee or entrepreneur, it’ll also make you a better person. Follow leaders like Bill Gates with book recommendations and actually read those things – again, it’ll just make you a better, more well-rounded and ultimately happier human.


M7: What is your superpower?
AL:
 Curiosity. I am interested in everything. And everyone. Everyone has a story and I love hearing them. I learn a lot from that and have more stories to tell and more knowledge to connect new knowledge to.

ABOUT LEADMD

LeadMD is the #1 performance marketing consultancy that leverages best-in-class technology to make your vision actionable and your outcomes measurable. Breaking down the typical siloes of technology and strategy, LeadMD collaborates with clients to increase revenues, align teams and engage ideal customers. We’ve helped more than 3,500 high-growth companies succeed by building revenue engines that scale on top of marketing and sales platforms like Marketo, Adobe, Salesforce.com and dozens of others. For more information, visit www.leadmd.com or email us at go@leadmd.com

More C-Suite on deck

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Q&A with Bill Gianoukos, CEO at Goodpath

Media 7 | September 14, 2021

Bill Gianoukos, Co-founder and CEO of Goodpath, started Goodpath in 2018 with a mission to improve the ‘Quality Of Life’ for those suffering from chronic conditions. He is also a Mentor at Techstars, and an Investor at Wappier: Intelligent Revenue Management.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Q&A with Bill Gianoukos, CEO at Goodpath

Media 7 | September 14, 2021

Bill Gianoukos, Co-founder and CEO of Goodpath, started Goodpath in 2018 with a mission to improve the ‘Quality Of Life’ for those suffering from chronic conditions. He is also a Mentor at Techstars, and an Investor at Wappier: Intelligent Revenue Management.

Read More

Related News

HEALTHCARE ANALYTICS

XRHealth Announces its Virtual Therapeutic Care Solution for the Lenovo VRX Utilizing Snapdragon Spaces

PRNewswire | June 01, 2023

XRHealth, a Boston-based developer and operator of virtual treatment rooms, announces today their adoption of Snapdragon Spaces™ XR Developer Platform for the Lenovo ThinkReality VRX. The integration will enable XRHealth developers to create immersive experiences in AR/VR/MR for the healthcare industry. Lenovo's ThinkReality VRX is one of the first headsets launched with Snapdragon Spaces to empower developers to expand the XR ecosystem. Lenovo ThinkReality VRX will now be preloaded with XRHealth therapeutic solutions. "Snapdragon Spaces is created to provide application developers the software tools to build immersive XR solutions and innovate using immersive technology," said Martin Herdina, Senior Director, Product Management, XR. "XR Health brings impressive technology to the table in their virtual healthcare and therapy solution, and Qualcomm Technologies, Inc. is excited to work with them as part of its rapidly growing XR enterprise ecosystem." Lenovo and Qualcomm Technologies have long worked together to expand the enterprise metaverse and virtual workspaces. With XRHealth's adoption of Snapdragon Spaces, developers will be able to create immersive VR healthcare experiences on devices powered by Snapdragon®, offering developers the option to develop VR, AR, or MR experiences on the leading headsets for training and collaboration in 3D. Lenovo's ThinkReality VRX headset that will support both Snapdragon Spaces and XRHealth will be available in Q3 of 2023. "We are excited to integrate our solution on Snapdragon Spaces and Lenovo ThinkReality VRX to enable developers to build innovative experiences that will revolutionize therapeutic care," says Eran Orr, CEO of XRHealth. "We are honored to join Qualcomm Technologies' first cohort of companies developing on VRX using Snapdragon Spaces technology." This announcement comes at the heels of XRHealth announcing a merger with Amelia Virtual Care which has created a XR therapeutic powerhouse, addressing both physical and mental health issues. XRHealth will demonstrate the headset at AWE in Santa Clara, CA during May 31-June 2 at Lenovo's booth #219 and Qualcomm's booth #205 at Hall A. About XRHealth XRHealth operates state-of-the-art therapeutic care Virtual Rooms, utilizing proprietary FDA and CE-registered medical Extended Reality (XR) technology (virtual and augmented reality). XRHealth integrates immersive XR technology, licensed clinicians, and advanced data analytics on one platform, providing a comprehensive therapeutic care solution for patients to receive treatment from the comfort of their home. The company offers a variety of patent-pending solutions from rehabilitation services to cognitive assessment and training to pain management. XRHealth works with several world-renowned U.S. healthcare providers, hospitals, and rehabilitation centers. Founded in 2016, XRHealth is headquartered in Boston,

Read More

DIGITAL HEALTHCARE, MEDICAL DEVICES

Carbon Health Launches AI Charting in Its EHR Across All Clinics and Providers

Businesswire | June 06, 2023

Carbon Health announced the launch of hands-free charting — an AI-enabled notes assistant — in its proprietary EHR across each of its clinics and providers. Carbon Health’s EHR (electronic health records) platform is the first to deploy native AI-assisted charting at scale. With the patent-pending technology, Carbon Health has developed a way for providers to generate comprehensive and accurate medical notes more efficiently with the press of a record button. Built directly into the Carbon Health EHR and designed to fit seamlessly into a provider’s existing workflow, the integration saves time and enhances the patient-doctor connection. Without a screen between them and their patients, doctors can focus more time on care and less on typing. “The rapid development and deployment of hands-free charting advances Carbon Health's AI-enabled EHR and shows how quickly AI can have a real-world impact on care delivery,” said Carbon Health CEO Eren Bali. “Our vertically integrated model of providers, clinics, and software makes our system uniquely positioned to leverage AI technologies like GPT-4.” Early data shows immediate benefits for providers Efficiency: On average, the system generates a complete medical chart in less than 4 minutes compared to 16 minutes for a manual chart Accuracy: 88% of the AI-generated text is accepted by the provider without edits Completeness: Charts are 2.5x more detailed than manual entry Hands-free charting starts with patient consent at the beginning of a visit. Once consent is obtained, with a simple press of a record button in the Carbon Health EHR, audio is captured and transcribed using AWS Transcribe Medical. The transcript is then combined with other patient information such as demographics, vitals, lab results, and manually added notes from the provider. Within minutes, a visit summary is auto-generated in the patient’s chart, allowing a provider to review, adjust, and finalize it as the medical decision-maker, all within the EHR. “It's tough to imagine my shifts without this technology,” said Dr. Caesar Djavaherian, Carbon Health Chief Clinical Innovation Officer. “Carbon Health’s hands-free charting feature provides a level of detail and accuracy that we could never achieve with manual notes. I'm never going back.” In a pilot test, a Carbon Health clinic in San Francisco, CA, saw a 30% increase in patients compared to typical visit volume, without added stress on the team, thanks to the use of hands-free charting on the backend. This increase in throughput without an increase in administrative burden shows what’s possible when AI is seamlessly built into a team's day-to-day workflows. “It’s about eye contact over iPads,” said Bali. “For too long, providers have had to choose between connecting with their patients and taking notes. That will no longer be the case at Carbon Health clinics. We’re unlocking the ability for clinics to meet the needs of the community without trade-offs like burnout or exhaustion.” About Carbon Health Carbon Health is a modern healthcare company that offers in-person and virtual care for easier everyday health. By combining custom technology with expert care, Carbon Health enables patients to establish a direct relationship with an integrated team, monitor and manage their health on the go, and access care when and where they need it. Building on the success of its nationwide urgent care network, Carbon Health treats the full spectrum of needs – from acute issues to chronic conditions, as well as ongoing physical and mental health. The company is also expanding into value-based care through work with employers, health plans, health systems, and other ecosystem partners.

Read More

HEALTHCARE ANALYTICS

HeartBeam Enters into Strategic Alliance Agreement with Samsung

Businesswire | May 31, 2023

HeartBeam, Inc. a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, today announced that it has entered into a Strategic Alliance Agreement (SAA) with Samsung, extending the existing SAA between LIVMOR and Samsung. HeartBeam acquired the assets of LIVMOR earlier this year. Under the terms of the agreement, HeartBeam and Samsung will identify and define opportunities for collaboration, tapping the HeartBeam team's expertise and patented technology in the assessment and monitoring of cardiac symptoms. “The goal of this partnership is to bring standard of care for cardiac diagnostic capabilities to patients by utilizing cutting edge technologies of both Samsung and HeartBeam,” said Branislav Vajdic, Ph.D., HeartBeam CEO and Founder. “Our newly acquired state of the art, FDA cleared, Samsung watch-based arrhythmia detection tool, once integrated with the HeartBeam AIMIGo™ telehealth platform, presents a unique opportunity to extend our product capabilities well beyond what is currently available for cardiac patients outside of a medical setting.” Kevin Jones, Senior Director, Federal Healthcare, Samsung Electronics America, added, “The strategic collaboration between Samsung and LIVMOR was very successful, resulting in an FDA cleared solution for Atrial Fibrillation detection centered around the Samsung Galaxy watch and tablet running Samsung's defense-grade cyber-security system, Knox. We are excited that LIVMOR is now part of HeartBeam and look forward to continuing our successful collaboration. The potential of combining LIVMOR’s technology and the HeartBeam AIMIGo system holds significant promise to address major cardiac conditions for our veterans.” Founded in 2016, LIVMOR developed the Halo™ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring. The Halo system provides continuous monitoring of pulse rhythms for the detection of AF on-demand during the day and automatically overnight. Under the previous SAA, LIVMOR and Samsung developed a physician-prescribed and fully integrated patient care platform that provides extended monitoring of patient cardiovascular health in virtually any setting, using medical grade equipment. LIVMOR’s technology was commercially deployed within the VA Healthcare System in Dallas, Texas. “Thanks to our cooperation with LIVMOR and Samsung, we are able to treat some of the nation’s most at-risk patients as safely and effectively from the comfort of their homes as we would if they were sitting in an exam room,” said Dr. Jerrold Grodin, Department of Veterans Affairs, North Texas. “We’ve seen an increase in early adoption from patients when their physicians are also early adopters.” Among the available opportunities is a potential collaboration with the Department of Veterans Affairs through its Accelerating VA Innovation and Learning (AVAIL) program. In September, the VA announced that 17 companies had won spots in a potential five-year, $650 million healthcare technology research and development program. Participants provide subject-matter expertise to help the agency design, build and test novel platforms, services and care models that could be scaled into clinical production to support the Veterans Health Administration. One of the AVAIL program's awardees is Longview International Technology Solutions (LTS), a systems integration company. LIVMOR and Samsung have been designated as official collaborators with LTS for the AVAIL project. With the Company’s anticipated participation in the AVAIL project, HeartBeam could share its expertise in the assessment and monitoring of cardiac symptoms as it collaborates with Samsung to innovate and develop solutions for the VA, the largest integrated healthcare system in the U.S. "Veterans reported a rate of heart attacks more than twice that of non-veterans in one study," Dr. Vajdic added. "This shows that coronary artery disease is a significant problem for veterans, making improvements in heart attack detection at the VA particularly critical." About HeartBeam, Inc. HeartBeam, Inc. is a cardiac technology company that has developed the first and only 3D-vector ECG platform intended for patient use at home. By applying a suite of proprietary algorithms to simplify vector electrocardiography (VECG), the HeartBeam platform enables patients and their clinicians to assess their cardiac symptoms quickly and easily, so care can be expedited, if required. HeartBeam has two patented products in development. HeartBeam AIMI™ is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack. HeartBeam AIMIGo™ is the first and only credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms. HeartBeam AIMI and HeartBeam AIMIGo have not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA or other geographies.

Read More

HEALTHCARE ANALYTICS

XRHealth Announces its Virtual Therapeutic Care Solution for the Lenovo VRX Utilizing Snapdragon Spaces

PRNewswire | June 01, 2023

XRHealth, a Boston-based developer and operator of virtual treatment rooms, announces today their adoption of Snapdragon Spaces™ XR Developer Platform for the Lenovo ThinkReality VRX. The integration will enable XRHealth developers to create immersive experiences in AR/VR/MR for the healthcare industry. Lenovo's ThinkReality VRX is one of the first headsets launched with Snapdragon Spaces to empower developers to expand the XR ecosystem. Lenovo ThinkReality VRX will now be preloaded with XRHealth therapeutic solutions. "Snapdragon Spaces is created to provide application developers the software tools to build immersive XR solutions and innovate using immersive technology," said Martin Herdina, Senior Director, Product Management, XR. "XR Health brings impressive technology to the table in their virtual healthcare and therapy solution, and Qualcomm Technologies, Inc. is excited to work with them as part of its rapidly growing XR enterprise ecosystem." Lenovo and Qualcomm Technologies have long worked together to expand the enterprise metaverse and virtual workspaces. With XRHealth's adoption of Snapdragon Spaces, developers will be able to create immersive VR healthcare experiences on devices powered by Snapdragon®, offering developers the option to develop VR, AR, or MR experiences on the leading headsets for training and collaboration in 3D. Lenovo's ThinkReality VRX headset that will support both Snapdragon Spaces and XRHealth will be available in Q3 of 2023. "We are excited to integrate our solution on Snapdragon Spaces and Lenovo ThinkReality VRX to enable developers to build innovative experiences that will revolutionize therapeutic care," says Eran Orr, CEO of XRHealth. "We are honored to join Qualcomm Technologies' first cohort of companies developing on VRX using Snapdragon Spaces technology." This announcement comes at the heels of XRHealth announcing a merger with Amelia Virtual Care which has created a XR therapeutic powerhouse, addressing both physical and mental health issues. XRHealth will demonstrate the headset at AWE in Santa Clara, CA during May 31-June 2 at Lenovo's booth #219 and Qualcomm's booth #205 at Hall A. About XRHealth XRHealth operates state-of-the-art therapeutic care Virtual Rooms, utilizing proprietary FDA and CE-registered medical Extended Reality (XR) technology (virtual and augmented reality). XRHealth integrates immersive XR technology, licensed clinicians, and advanced data analytics on one platform, providing a comprehensive therapeutic care solution for patients to receive treatment from the comfort of their home. The company offers a variety of patent-pending solutions from rehabilitation services to cognitive assessment and training to pain management. XRHealth works with several world-renowned U.S. healthcare providers, hospitals, and rehabilitation centers. Founded in 2016, XRHealth is headquartered in Boston,

Read More

DIGITAL HEALTHCARE, MEDICAL DEVICES

Carbon Health Launches AI Charting in Its EHR Across All Clinics and Providers

Businesswire | June 06, 2023

Carbon Health announced the launch of hands-free charting — an AI-enabled notes assistant — in its proprietary EHR across each of its clinics and providers. Carbon Health’s EHR (electronic health records) platform is the first to deploy native AI-assisted charting at scale. With the patent-pending technology, Carbon Health has developed a way for providers to generate comprehensive and accurate medical notes more efficiently with the press of a record button. Built directly into the Carbon Health EHR and designed to fit seamlessly into a provider’s existing workflow, the integration saves time and enhances the patient-doctor connection. Without a screen between them and their patients, doctors can focus more time on care and less on typing. “The rapid development and deployment of hands-free charting advances Carbon Health's AI-enabled EHR and shows how quickly AI can have a real-world impact on care delivery,” said Carbon Health CEO Eren Bali. “Our vertically integrated model of providers, clinics, and software makes our system uniquely positioned to leverage AI technologies like GPT-4.” Early data shows immediate benefits for providers Efficiency: On average, the system generates a complete medical chart in less than 4 minutes compared to 16 minutes for a manual chart Accuracy: 88% of the AI-generated text is accepted by the provider without edits Completeness: Charts are 2.5x more detailed than manual entry Hands-free charting starts with patient consent at the beginning of a visit. Once consent is obtained, with a simple press of a record button in the Carbon Health EHR, audio is captured and transcribed using AWS Transcribe Medical. The transcript is then combined with other patient information such as demographics, vitals, lab results, and manually added notes from the provider. Within minutes, a visit summary is auto-generated in the patient’s chart, allowing a provider to review, adjust, and finalize it as the medical decision-maker, all within the EHR. “It's tough to imagine my shifts without this technology,” said Dr. Caesar Djavaherian, Carbon Health Chief Clinical Innovation Officer. “Carbon Health’s hands-free charting feature provides a level of detail and accuracy that we could never achieve with manual notes. I'm never going back.” In a pilot test, a Carbon Health clinic in San Francisco, CA, saw a 30% increase in patients compared to typical visit volume, without added stress on the team, thanks to the use of hands-free charting on the backend. This increase in throughput without an increase in administrative burden shows what’s possible when AI is seamlessly built into a team's day-to-day workflows. “It’s about eye contact over iPads,” said Bali. “For too long, providers have had to choose between connecting with their patients and taking notes. That will no longer be the case at Carbon Health clinics. We’re unlocking the ability for clinics to meet the needs of the community without trade-offs like burnout or exhaustion.” About Carbon Health Carbon Health is a modern healthcare company that offers in-person and virtual care for easier everyday health. By combining custom technology with expert care, Carbon Health enables patients to establish a direct relationship with an integrated team, monitor and manage their health on the go, and access care when and where they need it. Building on the success of its nationwide urgent care network, Carbon Health treats the full spectrum of needs – from acute issues to chronic conditions, as well as ongoing physical and mental health. The company is also expanding into value-based care through work with employers, health plans, health systems, and other ecosystem partners.

Read More

HEALTHCARE ANALYTICS

HeartBeam Enters into Strategic Alliance Agreement with Samsung

Businesswire | May 31, 2023

HeartBeam, Inc. a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, today announced that it has entered into a Strategic Alliance Agreement (SAA) with Samsung, extending the existing SAA between LIVMOR and Samsung. HeartBeam acquired the assets of LIVMOR earlier this year. Under the terms of the agreement, HeartBeam and Samsung will identify and define opportunities for collaboration, tapping the HeartBeam team's expertise and patented technology in the assessment and monitoring of cardiac symptoms. “The goal of this partnership is to bring standard of care for cardiac diagnostic capabilities to patients by utilizing cutting edge technologies of both Samsung and HeartBeam,” said Branislav Vajdic, Ph.D., HeartBeam CEO and Founder. “Our newly acquired state of the art, FDA cleared, Samsung watch-based arrhythmia detection tool, once integrated with the HeartBeam AIMIGo™ telehealth platform, presents a unique opportunity to extend our product capabilities well beyond what is currently available for cardiac patients outside of a medical setting.” Kevin Jones, Senior Director, Federal Healthcare, Samsung Electronics America, added, “The strategic collaboration between Samsung and LIVMOR was very successful, resulting in an FDA cleared solution for Atrial Fibrillation detection centered around the Samsung Galaxy watch and tablet running Samsung's defense-grade cyber-security system, Knox. We are excited that LIVMOR is now part of HeartBeam and look forward to continuing our successful collaboration. The potential of combining LIVMOR’s technology and the HeartBeam AIMIGo system holds significant promise to address major cardiac conditions for our veterans.” Founded in 2016, LIVMOR developed the Halo™ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring. The Halo system provides continuous monitoring of pulse rhythms for the detection of AF on-demand during the day and automatically overnight. Under the previous SAA, LIVMOR and Samsung developed a physician-prescribed and fully integrated patient care platform that provides extended monitoring of patient cardiovascular health in virtually any setting, using medical grade equipment. LIVMOR’s technology was commercially deployed within the VA Healthcare System in Dallas, Texas. “Thanks to our cooperation with LIVMOR and Samsung, we are able to treat some of the nation’s most at-risk patients as safely and effectively from the comfort of their homes as we would if they were sitting in an exam room,” said Dr. Jerrold Grodin, Department of Veterans Affairs, North Texas. “We’ve seen an increase in early adoption from patients when their physicians are also early adopters.” Among the available opportunities is a potential collaboration with the Department of Veterans Affairs through its Accelerating VA Innovation and Learning (AVAIL) program. In September, the VA announced that 17 companies had won spots in a potential five-year, $650 million healthcare technology research and development program. Participants provide subject-matter expertise to help the agency design, build and test novel platforms, services and care models that could be scaled into clinical production to support the Veterans Health Administration. One of the AVAIL program's awardees is Longview International Technology Solutions (LTS), a systems integration company. LIVMOR and Samsung have been designated as official collaborators with LTS for the AVAIL project. With the Company’s anticipated participation in the AVAIL project, HeartBeam could share its expertise in the assessment and monitoring of cardiac symptoms as it collaborates with Samsung to innovate and develop solutions for the VA, the largest integrated healthcare system in the U.S. "Veterans reported a rate of heart attacks more than twice that of non-veterans in one study," Dr. Vajdic added. "This shows that coronary artery disease is a significant problem for veterans, making improvements in heart attack detection at the VA particularly critical." About HeartBeam, Inc. HeartBeam, Inc. is a cardiac technology company that has developed the first and only 3D-vector ECG platform intended for patient use at home. By applying a suite of proprietary algorithms to simplify vector electrocardiography (VECG), the HeartBeam platform enables patients and their clinicians to assess their cardiac symptoms quickly and easily, so care can be expedited, if required. HeartBeam has two patented products in development. HeartBeam AIMI™ is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack. HeartBeam AIMIGo™ is the first and only credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms. HeartBeam AIMI and HeartBeam AIMIGo have not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA or other geographies.

Read More

Spotlight

LeadMD

LeadMD

LeadMD is the #1 performance marketing consultancy that leverages best-in-class technology to make your vision actionable and your outcomes measurable. Breaking down the typical siloes of technology and strategy, LeadMD collaborates with clients to increase revenues, align teams and engage ideal cus...

Events

Resources